VXRT News and Press, Vaxart Inc. From 06/29/20

Last week, the top-performing biotech stocks had something in common and by now you can probably guess exactly what that was. You got it. They both delivered positive press releases regarding their respective coronavirus vaccine candidates. Data source: Yahoo! Finance. Continue reading

BioHiTech Global (NASDAQ: BHTG ) +89%  on potential demand for Altapure disinfectant in COVID-19. More news on: BioHiTech Global, Inc., Kiniksa Pharmaceuticals, Ltd., CleanSpark, Inc., Stocks on the move, , Read more ...

Vaxart (NASDAQ: VXRT) and VBI Vaccines (NASDAQ: VBIV) are both young vaccine companies seeking to develop a vaccine for COVID-19. Neither company is profitable, but both stocks have experienced triple-digit growth in the last three months. Future stock growth stemming from advances in v...

Vaccine startup Vaxart (NASDAQ: VXRT) announced Thursday morning that it was initiating a memorandum of understanding with Attwill Medical Solutions Sterilflow. The latter company will produce components for Vaxart's COVID-19 vaccine candidate currently in preclinical development, and Vaxart...

Shares of Vaxart (NASDAQ: VXRT) soared on Friday after the biotech company said that its oral COVID-19 vaccine had been selected to receive funding from a federal government program aiming to deliver hundreds of millions of safe and effective coronavirus vaccine doses to Americans by Janua...

Gainers:  MDC Partners (NASDAQ: MDCA )  +95% . More news on: MDC Partners Inc., Vaxart, Inc., iBio, Inc., Stocks on the move, , Read more ...

Vaxart (NASDAQ: VXRT ) is surging for the second day in a row, up 70% pre-market, after the U.S. Government selected their oral vaccine as eligible to participate in a non-human study organized and funded as part of Operation "Warp Speed." More news on: Vaxart, Inc., AstraZeneca PLC, Jo...

MDC Partners (NASDAQ: MDCA ) +169%  on potential business combination with Stagwell. More news on: MDC Partners Inc., Vaxart, Inc., iBio, Inc., Stocks on the move, , Read more ...

SOUTH SAN FRANCISCO, Calif., June 26, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that its oral COVID-19 vaccine has been selected to participate in a non-hum...

Vaxart (NASDAQ: VXRT ) +25% after-hours after touching a new all-time high $6.48 during today's trade before closing up 96%, after saying it signed an MoU with Attwill Medical Solutions Sterilflow to use AMS' resources for lyophilization development and large scale manufacturing includin...